These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30392930)

  • 21. Association of RPA with chromosomal replication origins requires an Mcm protein, and is regulated by Rad53, and cyclin- and Dbf4-dependent kinases.
    Tanaka T; Nasmyth K
    EMBO J; 1998 Sep; 17(17):5182-91. PubMed ID: 9724654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the Saccharomyces cerevisiae Cdc7-Dbf4 complex in the replication checkpoint.
    Ogi H; Wang CZ; Nakai W; Kawasaki Y; Masumoto H
    Gene; 2008 May; 414(1-2):32-40. PubMed ID: 18372119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functions of mammalian Cdc7 kinase in initiation/monitoring of DNA replication and development.
    Kim JM; Yamada M; Masai H
    Mutat Res; 2003 Nov; 532(1-2):29-40. PubMed ID: 14643427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cdk1-mediated phosphorylation of Cdc7 suppresses DNA re-replication.
    Knockleby J; Kim BJ; Mehta A; Lee H
    Cell Cycle; 2016 Jun; 15(11):1494-505. PubMed ID: 27105124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of stimulators and inhibitors of Cdc7 kinase in vitro.
    Kakusho N; Taniyama C; Masai H
    J Biol Chem; 2008 Jul; 283(28):19211-8. PubMed ID: 18442972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting cell division cycle 7 kinase: a new approach for cancer therapy.
    Montagnoli A; Moll J; Colotta F
    Clin Cancer Res; 2010 Sep; 16(18):4503-8. PubMed ID: 20647475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xenopus Cdc7 executes its essential function early in S phase and is counteracted by checkpoint-regulated protein phosphatase 1.
    Poh WT; Chadha GS; Gillespie PJ; Kaldis P; Blow JJ
    Open Biol; 2014 Jan; 4(1):130138. PubMed ID: 24403013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDC7 kinase complex as a molecular switch for DNA replication.
    Masai H; Sato N; Takeda T; Arai K
    Front Biosci; 1999 Dec; 4():D834-40. PubMed ID: 10577390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cdc7 kinase - a new target for drug development.
    Swords R; Mahalingam D; O'Dwyer M; Santocanale C; Kelly K; Carew J; Giles F
    Eur J Cancer; 2010 Jan; 46(1):33-40. PubMed ID: 19815406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of action of a dual Cdc7/Cdk9 kinase inhibitor against quiescent and proliferating CLL cells.
    Natoni A; Murillo LS; Kliszczak AE; Catherwood MA; Montagnoli A; Samali A; O'Dwyer M; Santocanale C
    Mol Cancer Ther; 2011 Sep; 10(9):1624-34. PubMed ID: 21768328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xenopus cdc7 function is dependent on licensing but not on XORC, XCdc6, or CDK activity and is required for XCdc45 loading.
    Jares P; Blow JJ
    Genes Dev; 2000 Jun; 14(12):1528-40. PubMed ID: 10859170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analyses of mouse ASK, an activation subunit for Cdc7 kinase, using conditional ASK knockout ES cells.
    Yamashita N; Kim JM; Koiwai O; Arai K; Masai H
    Genes Cells; 2005 Jun; 10(6):551-63. PubMed ID: 15938714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA Replication Dynamics and Cellular Responses to ATP Competitive CDC7 Kinase Inhibitors.
    Rainey MD; Quachthithu H; Gaboriau D; Santocanale C
    ACS Chem Biol; 2017 Jul; 12(7):1893-1902. PubMed ID: 28560864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers.
    Rodriguez-Acebes S; Proctor I; Loddo M; Wollenschlaeger A; Rashid M; Falzon M; Prevost AT; Sainsbury R; Stoeber K; Williams GH
    Am J Pathol; 2010 Oct; 177(4):2034-45. PubMed ID: 20724597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Claspin recruits Cdc7 kinase for initiation of DNA replication in human cells.
    Yang CC; Suzuki M; Yamakawa S; Uno S; Ishii A; Yamazaki S; Fukatsu R; Fujisawa R; Sakimura K; Tsurimoto T; Masai H
    Nat Commun; 2016 Jul; 7():12135. PubMed ID: 27401717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Essential role of phosphorylation of MCM2 by Cdc7/Dbf4 in the initiation of DNA replication in mammalian cells.
    Tsuji T; Ficarro SB; Jiang W
    Mol Biol Cell; 2006 Oct; 17(10):4459-72. PubMed ID: 16899510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A second human Dbf4/ASK-related protein, Drf1/ASKL1, is required for efficient progression of S and M phases.
    Yoshizawa-Sugata N; Ishii A; Taniyama C; Matsui E; Arai K; Masai H
    J Biol Chem; 2005 Apr; 280(13):13062-70. PubMed ID: 15668232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DBF4, not DRF1, is the crucial regulator of CDC7 kinase at replication forks.
    Göder A; Maric CA; Rainey MD; O'Connor A; Cazzaniga C; Shamavu D; Cadoret JC; Santocanale C
    J Cell Biol; 2024 Aug; 223(8):. PubMed ID: 38865090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ATR Restrains DNA Synthesis and Mitotic Catastrophe in Response to CDC7 Inhibition.
    Rainey MD; Bennett D; O'Dea R; Zanchetta ME; Voisin M; Seoighe C; Santocanale C
    Cell Rep; 2020 Sep; 32(9):108096. PubMed ID: 32877678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach.
    Cheng AN; Lo YK; Lin YS; Tang TK; Hsu CH; Hsu JT; Lee AY
    EBioMedicine; 2018 Oct; 36():241-251. PubMed ID: 30293817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.